Objective evaluation of cyclandelate in treatment of intermittent claudication associated with arteriosclerosis obliterans.
D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000150:complications*; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000627:therapeutic use*